Search for: "US FOOD AND DRUG ADMINISTRATION"
Results 401 - 420
of 15,997
Sort by Relevance
|
Sort by Date
12 Feb 2024, 7:05 am
Food and Drug Administration (FDA) to guide patent examiners in the evaluation and treatment of Rule 132 declarations. [read post]
12 Feb 2024, 6:00 am
Patent and Trademark Office (USPTO), and former heads of NIST itself, across both Democratic and Republican administrations. [read post]
9 Feb 2024, 12:03 pm
Its effects increase in a dose-proportional manner, and a steady state is achieved after four to five weeks of once-weekly administration. [read post]
9 Feb 2024, 11:08 am
The Food and Drug Administration (FDA) relies on broad judicial deference granted by Chevron, with the primary goal of utilizing scientific and clinical expertise to protect the health and safety of the public. [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
7 Feb 2024, 1:20 pm
Food and Drug Administration. [read post]
6 Feb 2024, 9:05 pm
” The bipartisan commenters continued to say: “Changes in FSIS animal raising claim requirements must also be considered in consultation with the Food and Drug Administration (FDA) since a policy shift could also impact FDA regulated products (e.g., dairy and shell eggs). [read post]
6 Feb 2024, 3:58 pm
Food and Drug Administration (FDA) receives more than 100,000 U.S. reports each year associated with a suspected medication error An estimated 800,000 preventable medication‐related injuries occur every year in long‐term care facilities in the U.S. [read post]
6 Feb 2024, 3:38 pm
” Investigators from the CDC and the Food and Drug Administration are interviewing patients about what foods they ate before they became sick. [read post]
